1. Thalidomide

   Case report 04 May 2019 Pages: 351 - 351

2. Thrombin

   Case report 04 May 2019 Pages: 352 - 352

3. Ticagrelor

   Case report 04 May 2019 Pages: 353 - 353

4. Tirabrutinib

   Case report 04 May 2019 Pages: 354 - 354

5. Tofacitinib

   Case report 04 May 2019 Pages: 355 - 355

6. Trametinib

   Case report 04 May 2019 Pages: 356 - 356

7. Trastuzumab

   Case report 04 May 2019 Pages: 357 - 357

8. Trastuzumab

   Case report 04 May 2019 Pages: 358 - 358

9. Tretinoin

   Case report 04 May 2019 Pages: 359 - 359

10. Triamcinolone

    Case report 04 May 2019 Pages: 360 - 360

11. Triamcinolone

    Case report 04 May 2019 Pages: 361 - 361

12. Tumour-necrosis-factor-inhibitors

    Case report 04 May 2019 Pages: 362 - 362

13. Ulipristal

    Case report 04 May 2019 Pages: 363 - 363

14. Ustekinumab

    Case report 04 May 2019 Pages: 364 - 364

15. Valproic acid

    Case report 04 May 2019 Pages: 365 - 365

16. Vancomycin

    Case report 04 May 2019 Pages: 366 - 366

17. Vemurafenib

    Case report 04 May 2019 Pages: 367 - 367

18. Vismodegib

    Case report 04 May 2019 Pages: 368 - 368

19. Warfarin

    Case report 04 May 2019 Pages: 369 - 369

20. Warfarin

    Case report 04 May 2019 Pages: 370 - 370